New top genomics official at FDA
Executive Summary
Issam Zineh replaces Felix Frueh as FDA Associate Director for Genomics in the Office of Clinical Pharmacology in the Office of Translational Sciences. Zineh comes from the University of Florida's Pharmacogenomics Center, where he was associate director. His specialty is the immunomodulatory effects and pharmacogenomics of cardiovascular and endocrine drugs. Frueh has joined Medco Health Solutions as vice president of research and development, personalized medicine
You may also be interested in...
Genomics and rare drug reactions
Genomics are an important next step to improving predictive approaches to early testing for idiosyncratic, rare drug reactions, said C. George Rochester, lead mathematical statistician for the Quantitative Safety and Pharmacoepidemiology Group at CDER, at a recent drug safety meeting hosted by DIA and PhRMA. "If we look at the field of ... statistical genetics, that has a lot of big hope; there's a lot of emphasis on genomics and the hope that genomics is going to answer maybe almost all our questions," Rochester said. While admitting that genomics won't answer every question, looking at how proteins bond and behave has a lot of promise, he said. Rochester also stressed the importance of finding a multidisciplinary approach to improving predictive markers. Issam Zineh recently replaced Felix Frueh as FDA Associate Director for Genomics in the Office of Clinical Pharmacology in the Office of Translational Sciences (1"The Pink Sheet," Nov. 3, 2008, In Brief)
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.